| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | PARATEK PHARMACEUTICALS INC | 1,301,413 | 18,103,000 | 18.96% | ||
| 2 | Proteon Therapeutics | 2,017,872 | 16,264,000 | 17.03% | ||
| 3 | SIENTRA INC | 2,199,012 | 14,470,000 | 15.15% | ||
| 4 | TOBIRA THERAPEUTICS INC | 589,244 | 7,377,000 | 7.72% | ||
| 5 | CEMPRA INC | 383,935 | 6,331,000 | 6.63% | ||
| 6 | CHIASMA INC | 2,080,595 | 6,013,000 | 6.30% | ||
| 7 | LOMBARD MEDICAL INC | 3,473,452 | 3,786,000 | 3.96% | ||
| 8 | Innocoll | 555,555 | 3,067,000 | 3.21% | ||
| 9 | Dicerna Pharmaceuticals | 945,757 | 2,828,000 | 2.96% | ||
| 10 | CymaBay Therapeutics | 1,600,000 | 2,800,000 | 2.93% | ||
| 11 | CELLECTIS S A | 100,000 | 2,659,000 | 2.78% | ||
| 12 | DERMIRA INC | 70,000 | 2,047,000 | 2.14% | ||
| 13 | ADAPTIMMUNE THERAPEUTICS PLC | 250,000 | 2,033,000 | 2.13% | ||
| 14 | SENSEONICS HOLDINGS INC | 516,882 | 2,026,000 | 2.12% | ||
| 15 | IMMUNE DESIGN CORP COM | 197,300 | 1,610,000 | 1.69% | ||
| 16 | AURINIA PHARMACEUTICALS INC | 512,036 | 1,388,000 | 1.45% | ||
| 17 | ANTHERA PHARMACEUTICALS I | 437,994 | 1,349,000 | 1.41% | ||
| 18 | REGULUS THERAPEUTICS INC | 327,350 | 943,000 | 0.99% | ||
| 19 | OncoGenex Pharmaceuticals Inc | 396,104 | 400,000 | 0.42% | ||
| 20 | EPIRUS BIOPHARMA | 7,896 | 4,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-019505, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
